Mayo Clinic researchers collaborated on a new study led by Eli Lilly showing that the drug abemaciclib improves survival for people with high-risk, early-stage breast cancer. In the phase 3 monarchE ...
A marijuana plant is seen at a medical marijuana dispensary in Egg Harbor Township, N.J., on March 22, 2019. WASHINGTON — An experimental medication made from marijuana successfully reduced back pain ...
The proposed federal budget would see drastic cuts made to most of the agencies that fund science. The sheer magnitude of the cuts—including a 40 percent slashing of money going to the National ...
Judged by its actions, the Trump Administration supports drug shortages. Clearly, this is not the President’s stated goal, but it is the inevitable result of his policies including his proposed drug ...
LECLAIRE, Iowa (ICD) - An Iowa nursing home administrator who also worked briefly for the state agency that inspects nursing homes has agreed to surrender her license after being accused of stealing ...
July 29 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Tuesday its drug for a type of blood cancer was more effective in a head-to-head study against AbbVie's (ABBV.N), opens new tab Imbruvica ...
(CREDIT: iStock Images) They studied 26,414 patients prescribed gabapentin for chronic low back pain, comparing them to an equal number who did not use the drug. This study covered patient records ...
July 11 (UPI) --A drug used to treat seizures, nerve pain and restless leg syndrome might be linked with increased risk of dementia, a new study says. Regular gabapentin use appeared to increase risk ...
Bedtime administration of olmesartan-amlodipine provided better control of nocturnal blood pressure (BP) with a 3.0 mm Hg greater reduction in nighttime systolic pressure than morning dosing, without ...
On April 15, 2025, President Trump signed the Lowering Drug Prices by Once Again Putting Americans First Executive Order (Executive Order). The Executive Order revives and expands several ...
David Geier, the man appointed by Health and Human Services Secretary Robert F. Kennedy Jr. to lead a federal study on the causes of autism, previously treated autistic children with puberty-blocking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback